Ayutara ...

Investor Contacts

IR and media contact details.

Key Contacts

Get in touch with our Investor Relations, Media, and General Inquiry teams.

Head of Investor Relations
Jessica Wong
ir@medisafetherapeutics.com
+1 (628) 555-0198
Schedule 1:1 Meeting
Media & Press Relations
Michael Rivera
press@medisafetherapeutics.com
+1 (628) 555-0271
Download Press Kit
General Inquiries
Support Team
info@medisafetherapeutics.com
+1 (628) 555-0100
Mon–Fri, 9AM–6PM PST

Global Offices

Visit us at our headquarters or regional offices worldwide.

San Francisco, CA (HQ)
123 Mission Street, Suite 1800
San Francisco, CA 94105
United States
SF Office
Boston, MA
456 Biotech Ave, Floor 12
Cambridge, MA 02142
United States
Boston Office
London, UK
1 Canary Wharf, Level 39
London E14 5AB
United Kingdom
London Office

Frequently Asked Questions

When is the next earnings call?
Our Q3 2025 earnings call is scheduled for November 18, 2025, at 8:00 AM PST. Register via the Investor Relations portal.
How can I receive investor alerts?
Subscribe to our mailing list below or follow us on LinkedIn and X for real-time updates on filings, presentations, and events.
Where are SEC filings available?
All SEC filings (10-K, 10-Q, 8-K) are available on our Investor Relations page and the SEC EDGAR database.

Stay Informed

Join 15,000+ investors receiving quarterly updates, clinical trial results, and exclusive webcast access.